神经递质障碍患者队列的脑MRI体积学研究
本研究对西班牙神经递质相关疾病国际工作组队列中15例患者(8例单胺类、7例氨基酸类障碍)的3D T1加权脑图像进行体积分析,并与按性别和年龄匹配的健康个体比较。患者总体脑组织体积较小,且似乎与临床严重程度相关;识别出以右侧颞横回和双侧枕回为特征的体积缺损模式,严重病例具有独特模式,琥珀酸半醛脱氢酶缺乏症患者的体积受累似乎随年龄加重。
要点
- 无论具体神经递质疾病类型,患者总脑组织体积均较小,且似乎与临床严重程度相关。
- 特征性体积缺损模式包括右侧颞横回和双侧枕回。
- 严重病例的独特模式涉及右侧扣带回中后部、左侧运动前区上部和小脑。
核心结论
- 尽管队列存在异质性且样本量有限,但发现了新颖且相关的数据:总体体积缺损似乎是严重程度的标志物,与特定神经递质疾病无关,也独立于常规神经影像所获信息;个体脑结构的体积评估可能有助于深入了解病理生理、疾病严重程度和特定临床特征。
研究设计与样本
- 对西班牙神经递质相关疾病国际工作组队列中15例患者的3D T1加权脑图像进行体积分析(8例单胺类障碍、7例氨基酸类障碍),并与按性别和年龄匹配的健康个体比较。
关键影像表现/征象
- 患者显示总脑组织体积较小,似乎与临床严重程度相关。
- 识别出特征性体积缺损模式,包括右侧颞横回和双侧枕回。
- 严重病例具有独特模式,包括右侧扣带回中后部、左侧运动前区上部和小脑。
- 在琥珀酸半醛脱氢酶缺乏症中,体积受累似乎随生命进程加重。
局限性
- 队列存在异质性且样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Inborn errors of neurotransmitters are rare monogenic diseases. In general, conventional neuroimaging is not useful for diagnosis. Nevertheless, advanced neuroimaging techniques could provide novel diagnosis and prognosis biomarkers. We aim to describe cerebral volumetric findings in a group of Spanish patients with neurotransmitter disorders.
METHODS: Fifteen 3D T1-weighted brain images from the International Working Group on Neurotransmitter related Disorders Spanish cohort were assessed (eight with monoamine and seven with amino acid disorders). Volumes of cortical and subcortical brain structures were obtained for each patient and then compared with those of two healthy individuals matched by sex and age.
RESULTS: Regardless of the underlying disease, patients showed a smaller total cerebral tissue volume, which was apparently associated with clinical severity. A characteristic volumetric deficit pattern, including the right Heschl gyrus and the bilateral occipital gyrus, was identified. In severe cases, a distinctive pattern comprised the middle and posterior portions of the right cingulate, the left superior motor area and the cerebellum. In succinate semialdehyde dehydrogenase deficiency, volumetric affection seems to worsen over life.
CONCLUSION: Despite the heterogeneity and limited size of our cohort, we found novel and relevant data. Total volume deficit appears to be a marker of severity, regardless of the specific neurotransmitter disease and irrespective of the information obtained from conventional neuroimaging. Volumetric assessment of individual brain structures could provide a deeper knowledge about pathophysiology, disease severity and specific clinical traits.
引用
- Alfonsi, Stephan-Otto, Cortès-Saladelafont, et al. Volumetric study of brain MRI in a cohort of patients with neurotransmitter disorders. Neuroradiology. 2022. PMID: 35662359. doi:10.1007/s00234-022-02989-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。